Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Modern Rheumatology|November 21, 2013
Clinicopathological features of IgG4-related disease complicated with orbital involvementChihiro Hagiya, Hiroto Tsuboi, Masahiro Yokosawa, et al.
Modern Rheumatology|February 14, 2016
Association of anti-Ro/SSA antibody with response to biologics in patients with rheumatoid arthritisShinya Hagiwara, Hiroto Tsuboi, Fumika Honda, et al.
Modern Rheumatology|December 29, 2012
Validation of different sets of criteria for the diagnosis of Sjögren's syndrome in Japanese patientsHiroto Tsuboi, Shinya Hagiwara, Hiromitsu Asashima, et al.
Modern Rheumatology|September 12, 2014
Efficacy and safety of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis: rheumatoid arthritis with orencia trial toward Sjögren's syndrome Endocrinopathy (ROSE) trial-an open-label, one-year, prospective study-Interim analysis of 32 patients for 24 weeksHiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, et al.
Rheumatology International|January 3, 2024
An overlapping case of IgG4-related disease and systemic lupus erythematosus treated with belimumab: a case-based reviewMegumi Iwamoto, Hiromitsu Asashima, Toshiki Sugita, et al.
Internal Medicine (Tokyo, Japan)|June 3, 2026
Native Wrist Septic Arthritis due to Corynebacterium striatum after Short-Term Systemic GlucocorticoidsYoshinori Tani, Toshiki Sugita, Akira Ikumi, et al.
Annals of the Rheumatic Diseases|March 24, 2017
Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patientsHiroto Tsuboi, Shinya Hagiwara, Hiromitsu Asashima, et al.
Modern Rheumatology|July 27, 2016
Effectiveness of abatacept for patients with Sjögren's syndrome associated with rheumatoid arthritis. An open label, multicenter, one-year, prospective study: ROSE (Rheumatoid Arthritis with Orencia Trial toward Sjögren's syndrome Endocrinopathy) trialHiroto Tsuboi, Isao Matsumoto, Shinya Hagiwara, et al.
Small Methods|June 14, 2023
Microfluidic Immuno-Serolomic Assay Reveals Systems Level Association with COVID-19 Pathology and Vaccine ProtectionDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Biorxiv : the Preprint Server for Biology|September 12, 2022
Microfluidic immuno-serology assay revealed a limited diversity of protection against COVID-19 in patients with altered immunityDongjoo Kim, Giulia Biancon, Zhiliang Bai, et al.
Pageof 7